Smith & Nephew plc

LSE:SN. 주식 보고서

시가총액: UK£8.6b

Smith & Nephew 과거 수익 실적

과거 기준 확인 2/6

Smith & Nephew의 수입은 연평균 -18.5%의 비율로 감소해 온 반면, Medical Equipment 산업은 수입이 연평균 3.9%의 비율로 증가했습니다. 매출은 연평균 3%의 비율로 증가해 왔습니다. Smith & Nephew의 자기자본이익률은 5.9%이고 순이익률은 5.4%입니다.

주요 정보

-18.5%

수익 성장률

-18.5%

EPS 성장률

Medical Equipment 산업 성장-9.5%
매출 성장률3.0%
자기자본 수익률5.9%
순이익5.4%
다음 실적 업데이트25 Feb 2025

최근 과거 실적 업데이트

Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Aug 08
Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Recent updates

Investors Still Waiting For A Pull Back In Smith & Nephew plc (LON:SN.)

Oct 31
Investors Still Waiting For A Pull Back In Smith & Nephew plc (LON:SN.)

Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Sep 25
Some Investors May Be Worried About Smith & Nephew's (LON:SN.) Returns On Capital

Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Aug 08
Statutory Profit Doesn't Reflect How Good Smith & Nephew's (LON:SN.) Earnings Are

Smith & Nephew (LON:SN.) Will Be Hoping To Turn Its Returns On Capital Around

Jun 16
Smith & Nephew (LON:SN.) Will Be Hoping To Turn Its Returns On Capital Around

Smith & Nephew plc (LON:SN.) Not Flying Under The Radar

Apr 16
Smith & Nephew plc (LON:SN.) Not Flying Under The Radar

Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

Mar 16
Is Smith & Nephew plc (LON:SN.) Trading At A 30% Discount?

Capital Allocation Trends At Smith & Nephew (LON:SN.) Aren't Ideal

Feb 21
Capital Allocation Trends At Smith & Nephew (LON:SN.) Aren't Ideal

Is Smith & Nephew plc (LON:SN.) Trading At A 36% Discount?

Dec 15
Is Smith & Nephew plc (LON:SN.) Trading At A 36% Discount?

Is Smith & Nephew (LON:SN.) Using Too Much Debt?

Nov 30
Is Smith & Nephew (LON:SN.) Using Too Much Debt?

Smith & Nephew (LON:SN.) Could Be Struggling To Allocate Capital

Oct 29
Smith & Nephew (LON:SN.) Could Be Struggling To Allocate Capital

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Sep 11
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 65% Above Its Share Price

Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Aug 19
Smith & Nephew (LON:SN.) Has A Pretty Healthy Balance Sheet

Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Jul 17
Investors Could Be Concerned With Smith & Nephew's (LON:SN.) Returns On Capital

Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Jun 11
Smith & Nephew plc (LON:SN.) Shares Could Be 22% Below Their Intrinsic Value Estimate

Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

May 09
Smith & Nephew (LON:SN.) Seems To Use Debt Quite Sensibly

Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Apr 09
Smith & Nephew (LON:SN.) Will Want To Turn Around Its Return Trends

Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

Feb 09
Calculating The Intrinsic Value Of Smith & Nephew plc (LON:SN.)

We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

Nov 21
We Think Smith & Nephew (LON:SN.) Can Stay On Top Of Its Debt

Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Nov 08
Returns On Capital Signal Tricky Times Ahead For Smith & Nephew (LON:SN.)

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

Oct 26
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 99% Above Its Share Price

These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

Aug 11
These 4 Measures Indicate That Smith & Nephew (LON:SN.) Is Using Debt Reasonably Well

There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital

Jul 28
There Are Reasons To Feel Uneasy About Smith & Nephew's (LON:SN.) Returns On Capital

Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price

Jun 26
Smith & Nephew plc's (LON:SN.) Intrinsic Value Is Potentially 58% Above Its Share Price

수익 및 비용 분석

Smith & Nephew 수익 창출 및 지출 방식. 최근 보고된 수익 기준, LTM 기준.

수익 및 매출 내역

LSE:SN. 수익, 비용 및 수입 (USD Millions )
날짜수익수익G+A 비용R&D 비용
29 Jun 245,6423052,942291
29 Mar 245,5962842,916306
31 Dec 235,5492632,890320
30 Sep 235,4492412,816324
01 Jul 235,3492182,741327
01 Apr 235,2822212,718331
31 Dec 225,2152232,695335
30 Sep 225,2143602,680344
02 Jul 225,2134962,665352
02 Apr 225,2135102,651351
31 Dec 215,2125242,637349
30 Sep 215,1685392,607340
03 Jul 215,1245532,576330
03 Apr 214,8425012,508319
31 Dec 204,5604482,439307
30 Sep 204,6244202,470304
27 Jun 204,6883912,501301
27 Mar 204,9134962,518297
31 Dec 195,1386002,534292
30 Sep 195,0446492,449281
29 Jun 194,9496982,364269
29 Mar 194,9276812,374258
31 Dec 184,9046632,384246
30 Sep 184,8876902,450239
30 Jun 184,8697172,496232
31 Mar 184,8177422,453228
31 Dec 174,7657672,419223
30 Sep 174,7218172,346224
01 Jul 174,6778672,282224
01 Apr 174,6738262,269227
31 Dec 164,6697842,255230
30 Sep 164,6805702,515228
02 Jul 164,6903562,393225
02 Apr 164,6623832,363224
31 Dec 154,6344102,524222
30 Sep 154,7025132,333224
27 Jun 154,6695572,326225
27 Mar 154,6804992,375234
31 Dec 144,6175012,323235
27 Sep 144,5435032,285239
28 Jun 144,4225232,201241
29 Mar 144,3495632,124235
31 Dec 134,3515562,149231

양질의 수익: SN. 에는 $264.0M 큰 일회성 손실이 있습니다. $264.0M 은 지난 12개월 간의 재무 결과에 29th June, 2024 까지 영향을 미쳤습니다.

이익 마진 증가: SN. 의 현재 순이익 이익률 (5.4%) 작년보다 높습니다 (4.1%).

잉여현금흐름 대 수익 분석

과거 수익 성장 분석

수익추이: SN. 의 수입은 지난 5년 동안 매년 18.5% 씩 감소했습니다.

성장 가속화: 지난 1년간 SN. 의 수익 증가율( 39.9% )은 연간 평균( -18.5% 초과합니다. ).

수익 대 산업: 지난 1년간 SN. 수익 성장( 39.9% )은 Medical Equipment 업계 39.9% 능가하지 못했습니다. 39.9%.

자기자본 수익률

높은 ROE: SN. 의 자본 수익률( 5.9% )은 낮음으로 간주됩니다.

자산 수익률

고용 자본 수익률

과거 성과가 우수한 기업 찾기

7D

1Y

7D

1Y

7D

1Y